Milnacipran. A review of its use in depression (Q34067692)

30 July 2017

1 reference

title

Milnacipran. A review of its use in depression (English)

1 reference

30 July 2017

C M Spencer

1

1 reference

30 July 2017

M I Wilde

series ordinal

2

1 reference

30 July 2017

publication date

1 September 1998

1 reference

30 July 2017

1 reference

30 July 2017

volume

56

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

405-427

1 reference

Interest of a loading dose of milnacipran in endogenous depressive inpatients. Comparison with the standard regimen and with fluvoxamine

30 July 2017

cites work

1 reference

12 December 2020

Development of a Rating Scale for Primary Depressive Illness

1 reference

12 December 2020

Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat

1 reference

12 December 2020

Pharmacokinetics of milnacipran in liver impairment

1 reference

12 December 2020

Comparative in vivo and in vitro study of the cardiac effects of midalcipran and imipramine

1 reference

12 December 2020

Effect of milnacipran and desipramine on noradrenergic alpha 2-autoreceptor sensitivity

1 reference

12 December 2020

Monoamine uptake inhibition by plasma from healthy volunteers after single oral doses of the antidepressant milnacipran

1 reference

12 December 2020

Effect of antidepressant drugs on monoamine synthesis in brain in vivo

1 reference

12 December 2020

Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression

1 reference

12 December 2020

Controlled comparison of milnacipran and fluoxetine in major depression

1 reference

12 December 2020

Clinical efficacy of milnacipran: placebo-controlled trials.

1 reference

12 December 2020

Contemporary management of depression

1 reference

12 December 2020

Preclinical pharmacology of milnacipran

1 reference

12 December 2020

1-Aryl-2-(aminomethyl)cyclopropanecarboxylic acid derivatives. A new series of potential antidepressants

1 reference

12 December 2020

Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.

1 reference

12 December 2020

Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients

1 reference

12 December 2020

Pharmacokinetics of milnacipran in comparison with other antidepressants

1 reference

12 December 2020

Efficacy and tolerability of milnacipran: an overview

1 reference

12 December 2020

Double-blind placebo-controlled study of milnacipran in hospitalized patients with major depressive disorders

1 reference

12 December 2020

The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants

1 reference

12 December 2020

Cost-effectiveness considerations for managed care systems: treating depression in primary care

1 reference

12 December 2020

Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode

1 reference

12 December 2020

Lack of effect of repeated administration of milnacipran, a double noradrenaline and serotonin reuptake inhibitor, on the beta-adrenoceptor-linked adenylate cyclase system in the rat cerebral cortex

1 reference

12 December 2020

Autoradiographic characterization of binding sites for [3H]milnacipran, a new antidepressant drug, and their relationship to the serotonin transporter in rat brain

1 reference

12 December 2020

Measuring the side effects of psychotropics: the behavioural toxicity of antidepressants.

1 reference

12 December 2020

Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug

1 reference

12 December 2020

Pharmacokinetics of milnacipran in renal impairment

1 reference

12 December 2020

Electroencephalographic and cardiovascular effects of milnaciplan hydrochloride (TN-912), a novel antidepressant

1 reference

12 December 2020

Milnacipran and selective serotonin reuptake inhibitors in major depression

1 reference

12 December 2020

Psychopharmacology of midalcipran, 1-phenyl-1-diethyl-amino-carbonyl-2-aminomethylcyclopropane hydrochloride (F 2207), a new potential antidepressant

1 reference

12 December 2020

Acute electrophysiological effects of intravenous milnacipran, a new antidepressant agent

1 reference

12 December 2020

Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats.

1 reference

12 December 2020

Long-term management of depression

1 reference

12 December 2020

A double-blind six months comparative study of milnacipran and clomipramine in major depressive disorder.

1 reference

12 December 2020

10.2165/00003495-199856030-00010

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1052014783

0 references

1 reference